Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections
2013/11/19 by Kresken, Michael, Von Müller, Lutz, Grabein, Béatrice +8
#610 Medical sciences #Medicine
paper · doi:10.3205/id000007
Abstract
[for full text, please go to the a.m. URL]
Related